|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US6040157A
(en)
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
EP0751992B1
(en)
|
1994-03-08 |
2005-11-09 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
|
CA2399148A1
(en)
|
2000-02-10 |
2001-08-16 |
Abbott Laboratories |
Antibodies that bind human interleukin-18 and methods of making and using
|
|
ME00546B
(me)
*
|
2000-02-21 |
2011-10-10 |
Serono Lab |
Korišćenje inhibitora il-18
|
|
US20020025317A1
(en)
*
|
2000-07-20 |
2002-02-28 |
Schering Ag |
Bispecific monoclonal antibodies to IL-12 and IL-18
|
|
JP2004505619A
(ja)
|
2000-08-04 |
2004-02-26 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
血管内皮増殖因子２
|
|
CN1326562C
(zh)
*
|
2001-01-29 |
2007-07-18 |
应用研究系统Ars股份公司 |
Il－18抑制剂制造治疗和/或预防心脏病的药物的应用
|
|
JP2004536579A
(ja)
|
2001-04-13 |
2004-12-09 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
血管内皮増殖因子２
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
EP1425028B1
(en)
*
|
2001-05-16 |
2009-12-16 |
Yeda Research And Development Co. Ltd. |
Use of il-18 inhibitors for the treatement or prevention of sepsis
|
|
US20040213786A1
(en)
*
|
2001-08-24 |
2004-10-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for treating T-cell mediated autoimmune diseases
|
|
PT2308888T
(pt)
|
2001-11-14 |
2017-05-03 |
Janssen Biotech Inc |
Anticorpos anti-il-6, composições, métodos e utilizações
|
|
US20040018195A1
(en)
*
|
2002-03-26 |
2004-01-29 |
Griswold Don Edgar |
Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
|
|
WO2003082922A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Markus Fritzsche |
Antibody against an epitope of the b. burgdorferi flagellar basal rod protein (fbrp)
|
|
US7253260B2
(en)
*
|
2002-04-17 |
2007-08-07 |
Smithkline Beecham Corporation |
Human IL-18 crystal structure
|
|
US7601351B1
(en)
|
2002-06-26 |
2009-10-13 |
Human Genome Sciences, Inc. |
Antibodies against protective antigen
|
|
EP1539235A2
(en)
|
2002-07-01 |
2005-06-15 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to reg iv
|
|
US20050271660A1
(en)
|
2002-09-06 |
2005-12-08 |
Alexion Pharmaceuticals, Inc. |
Nebulization of monoclonal antibodies for treating pulmonary diseases
|
|
US9415102B2
(en)
|
2002-09-06 |
2016-08-16 |
Alexion Pharmaceuticals, Inc. |
High concentration formulations of anti-C5 antibodies
|
|
AR047392A1
(es)
|
2002-10-22 |
2006-01-18 |
Wyeth Corp |
Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
EP1900753B1
(en)
|
2002-11-08 |
2017-08-09 |
Ablynx N.V. |
Method of administering therapeutic polypeptides, and polypeptides therefor
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
EP1558645B1
(en)
*
|
2002-11-08 |
2011-07-27 |
Ablynx N.V. |
Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
|
|
CA2523912A1
(en)
*
|
2003-04-30 |
2004-11-11 |
Japan Science And Technology Agency |
Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
AU2011224023C1
(en)
*
|
2003-11-12 |
2013-08-29 |
Abbvie Inc. |
IL-18 binding proteins
|
|
US7968684B2
(en)
*
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
|
US20050100965A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Tariq Ghayur |
IL-18 binding proteins
|
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
|
EP2177907B1
(en)
*
|
2004-06-30 |
2014-01-01 |
Atsuo Sekiyama |
Indicator agent for noninflammatory stress response and use therefor
|
|
US7141382B1
(en)
|
2004-10-12 |
2006-11-28 |
Parikh Chirag R |
Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
|
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
|
EP2500355A3
(en)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
NZ612578A
(en)
|
2005-08-19 |
2014-11-28 |
Abbvie Inc |
Dual variable domain immunoglobin and uses thereof
|
|
EP1928905B1
(de)
|
2005-09-30 |
2015-04-15 |
AbbVie Deutschland GmbH & Co KG |
Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
|
|
NZ616992A
(en)
*
|
2005-12-20 |
2015-07-31 |
Sbi Biotech Co Ltd |
Anti-ilt7 antibody
|
|
TWI417301B
(zh)
*
|
2006-02-21 |
2013-12-01 |
Wyeth Corp |
對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途
|
|
TWI422387B
(zh)
|
2006-05-25 |
2014-01-11 |
Glaxo Group Ltd |
免疫球蛋白
|
|
AU2007294731B2
(en)
|
2006-09-13 |
2014-04-17 |
Abbvie Inc. |
Cell culture improvements
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
EP2500416A1
(en)
|
2006-09-13 |
2012-09-19 |
Abbott Laboratories |
Cell culture improvements
|
|
JP5167275B2
(ja)
|
2007-01-04 |
2013-03-21 |
エスケー ケミカルズ カンパニー リミテッド |
明るさに優れたポリアリーレンスルフィド樹脂の製造方法
|
|
CA2691039A1
(en)
*
|
2007-05-29 |
2008-12-11 |
Yale University |
Il-18 and protein kinase r inhibition for the treatment of copd
|
|
CL2008002153A1
(es)
|
2007-07-24 |
2009-06-05 |
Amgen Inc |
Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
|
|
US20090203037A1
(en)
|
2007-12-27 |
2009-08-13 |
Abbott Laboratories |
Anti-T. Cruzi Antibodies and Methods of Use
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
SG190572A1
(en)
|
2008-04-29 |
2013-06-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
TW201006485A
(en)
|
2008-06-03 |
2010-02-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
CA2726087A1
(en)
|
2008-06-03 |
2009-12-10 |
Tariq Ghayur |
Dual variable domain immunoglobulins and uses thereof
|
|
US8188235B2
(en)
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
|
CN102149825B
(zh)
|
2008-07-08 |
2015-07-22 |
Abbvie公司 |
前列腺素e2双重可变结构域免疫球蛋白及其用途
|
|
MX2011004198A
(es)
*
|
2008-10-20 |
2011-05-24 |
Abbott Lab |
Anticerpos que unen a il-12 y metodos para purificar los mismos.
|
|
NZ592095A
(en)
|
2008-10-20 |
2013-01-25 |
Abbott Lab |
Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
|
|
MX2011004199A
(es)
*
|
2008-10-20 |
2011-05-24 |
Abbott Lab |
Anticuerpos que unen a il-18 y metodos para purificar los mismos.
|
|
BRPI0920572A8
(pt)
|
2008-10-20 |
2015-10-27 |
Abbott Lab |
Inativação viral durante a purificação dos anticorpos
|
|
BRPI0919879A2
(pt)
|
2008-10-29 |
2016-02-16 |
Wyeth Llc |
métodos para purificação de moléculas de ligação a antígeno de domínio único
|
|
CA2738243C
(en)
|
2008-10-29 |
2020-09-29 |
Wyeth Llc |
Formulations of single domain antigen binding molecules
|
|
US8168165B2
(en)
|
2008-12-23 |
2012-05-01 |
Abbott Laboratories |
Alkylated interleukin-18 compositions
|
|
US8349325B2
(en)
|
2008-12-23 |
2013-01-08 |
Abbott Laboratories |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
|
|
WO2011028811A2
(en)
|
2009-09-01 |
2011-03-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
BR112012008833A2
(pt)
|
2009-10-15 |
2015-09-08 |
Abbott Lab |
imunoglobulinas de dominio variavel duplo e usos das mesmas
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
MX2012006560A
(es)
|
2009-12-08 |
2012-10-05 |
Abbott Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
|
|
US20120308564A1
(en)
*
|
2010-02-09 |
2012-12-06 |
Andrew Ian Bayliffe |
Treatment of a metabolic disorder
|
|
US20110229921A1
(en)
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
|
|
EP3252072A3
(en)
|
2010-08-03 |
2018-03-14 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
JP2013539364A
(ja)
|
2010-08-26 |
2013-10-24 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリンおよびその使用
|
|
KR101712874B1
(ko)
*
|
2010-09-30 |
2017-03-07 |
쳉두 캉홍 바이오테크놀로지스 코. 리미티드 |
인간화 항 TNF α 항체 및 그의 항원 결합 단편 (Fab) 및 용도
|
|
US20120115244A1
(en)
|
2010-11-09 |
2012-05-10 |
Abbott Laboratories |
Materials and methods for immunoassay of pterins
|
|
MX2013007067A
(es)
*
|
2010-12-20 |
2013-11-01 |
Medimmune Ltd |
Anticuerpos anti-il-18 y sus usos.
|
|
CA2822288A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Medimmune, Llc |
Anti-c5/c5a/c5adesr antibodies and fragments
|
|
KR101839640B1
(ko)
|
2011-01-11 |
2018-03-16 |
제이에스알 가부시끼가이샤 |
감방사선성 수지 조성물 및 감방사선성 산 발생제
|
|
US9062106B2
(en)
|
2011-04-27 |
2015-06-23 |
Abbvie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
CA2855570A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
CA3204283A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
TW201333035A
(zh)
|
2011-12-30 |
2013-08-16 |
Abbvie Inc |
針對ｉｌ－１３及／或ｉｌ－１７之雙特異性結合蛋白
|
|
US8993248B2
(en)
|
2011-12-31 |
2015-03-31 |
Abbott Laboratories |
Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
|
|
EP3369746A1
(en)
|
2012-01-27 |
2018-09-05 |
AbbVie Deutschland GmbH & Co KG |
Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
HK1211981A1
(en)
|
2012-09-02 |
2016-06-03 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
US9376489B2
(en)
|
2012-09-07 |
2016-06-28 |
Novartis Ag |
IL-18 binding molecules
|
|
TW202037609A
(zh)
|
2012-11-01 |
2020-10-16 |
美商艾伯維有限公司 |
抗-vegf/dll4雙重可變區域免疫球蛋白及其用途
|
|
WO2014080866A1
(ja)
*
|
2012-11-21 |
2014-05-30 |
一般財団法人化学及血清療法研究所 |
新規なヒト抗ｉｌ－１８抗体
|
|
WO2014120265A1
(en)
|
2013-02-02 |
2014-08-07 |
Duke University |
Method of isolating circulating tumor cells
|
|
HK1207960A1
(en)
|
2013-03-12 |
2016-02-19 |
Abbvie Inc. |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
|
WO2014159579A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
US9499614B2
(en)
|
2013-03-14 |
2016-11-22 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
|
|
WO2014144280A2
(en)
|
2013-03-15 |
2014-09-18 |
Abbvie Inc. |
DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1β AND / OR IL-17
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
|
UA125204C2
(uk)
|
2013-09-05 |
2022-02-02 |
Аб2 Біо Са |
Застосування il-18-зв'язувального білка (il-18bp) при запальних захворюваннях
|
|
CA2923772A1
(en)
|
2013-09-17 |
2015-03-26 |
University Health Network (Uhn): Technology Development And Commercialization |
Agents directed against a cis rgma/neogenin interaction or lipid rafts and use of the same in methods of treatment
|
|
US9598667B2
(en)
|
2013-10-04 |
2017-03-21 |
Abbvie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
WO2016044736A1
(en)
*
|
2014-09-18 |
2016-03-24 |
Cell Signaling Technology, Inc. |
Altered antibodies and methods of making the same
|
|
AU2015336946A1
(en)
*
|
2014-10-23 |
2017-04-13 |
La Trobe University |
Fn14-binding proteins and uses thereof
|
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
|
US10882905B2
(en)
|
2015-03-05 |
2021-01-05 |
Ab2 Bio Sa |
IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
|
|
BR112017022845A2
(pt)
|
2015-04-23 |
2018-07-17 |
Nantomics, Llc |
neoepítopos de câncer
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
JP2018526404A
(ja)
|
2015-09-11 |
2018-09-13 |
アッヴィ・インコーポレイテッド |
再発型の多発性硬化症を治療するための方法
|
|
WO2017087784A1
(en)
|
2015-11-18 |
2017-05-26 |
Duke University |
Tumor infiltrating lymphocytes for treatment of cancer
|
|
AU2017231833B2
(en)
|
2016-03-10 |
2024-03-14 |
Viela Bio, Inc. |
ILT7 binding molecules and methods of using the same
|
|
EP3464372A1
(en)
|
2016-06-01 |
2019-04-10 |
AbbVie Inc. |
Anti-repulsive guidance molecule a (rgma) antagonistic antibodies for treating spinal cord injury and pain
|
|
WO2017218911A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
|
EP3279667A1
(en)
|
2016-08-02 |
2018-02-07 |
Abbott Laboratories |
Cardiac troponin i and copeptin as biomarkers for short-term mortality in acute exacerbation of chronic obstructive pulmonary disease (aecopd)
|
|
CN110383068A
(zh)
|
2016-10-03 |
2019-10-25 |
雅培实验室 |
评估患者样品中uch-l1状态的改进方法
|
|
US10324041B2
(en)
|
2016-12-21 |
2019-06-18 |
Abbott Japan Co., Ltd. |
Optical imaging system using lateral illumination for digital assays
|
|
US11047854B2
(en)
|
2017-02-06 |
2021-06-29 |
Abbott Japan Llc |
Methods for reducing noise in signal-generating digital assays
|
|
WO2018148278A1
(en)
|
2017-02-08 |
2018-08-16 |
Silbiotech, Inc. |
Methods for determining breast cancer risk
|
|
CA3055256A1
(en)
|
2017-03-09 |
2018-09-13 |
Mab Discovery Gmbh |
Antibodies specifically binding to human il-1r7
|
|
CA3261113A1
(en)
|
2017-03-23 |
2025-10-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
|
WO2018191531A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
|
ES3053676T3
(en)
|
2017-04-28 |
2026-01-23 |
Abbott Lab |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
US10866251B2
(en)
|
2017-05-25 |
2020-12-15 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
|
JP7269182B2
(ja)
|
2017-05-30 |
2023-05-08 |
アボット・ラボラトリーズ |
心臓トロポニンｉ及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法
|
|
US11169159B2
(en)
|
2017-07-03 |
2021-11-09 |
Abbott Laboratories |
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
|
|
US11426389B2
(en)
|
2017-07-28 |
2022-08-30 |
Duke University |
Compositions and methods for promoting hematopoietic stem cell regeneration
|
|
JP7379165B2
(ja)
|
2017-12-09 |
2023-11-14 |
アボット・ラボラトリーズ |
Ｇｆａｐとｕｃｈ－ｌ１との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法
|
|
EP3721233A2
(en)
|
2017-12-09 |
2020-10-14 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
|
CN111699391A
(zh)
|
2017-12-29 |
2020-09-22 |
雅培实验室 |
用于诊断和评估创伤性脑损伤的新型生物标志物和方法
|
|
WO2019194217A1
(ja)
*
|
2018-04-04 |
2019-10-10 |
株式会社ｍＡｂＰｒｏｔｅｉｎ |
検出感度の高いインターロイキン－１８タンパク質に対する抗体及びその応用
|
|
GB201809699D0
(en)
*
|
2018-06-13 |
2018-08-01 |
Singapore Health Serv Pte Ltd |
IL-11 antibodies
|
|
JP6892180B2
(ja)
*
|
2018-12-03 |
2021-06-23 |
株式会社ｍＡｂＰｒｏｔｅｉｎ |
活性型インターロイキン−１８タンパク質のネオエピトープを認識する抗体、及びその応用
|
|
JP2022515116A
(ja)
|
2018-12-20 |
2022-02-17 |
ザ・ユニバーシティ・オブ・シカゴ |
Ｒｎａ修飾の部位特異的な同定に関する組成物及び方法
|
|
EP3931573A1
(en)
|
2019-03-01 |
2022-01-05 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
|
KR102265432B1
(ko)
*
|
2019-08-20 |
2021-06-15 |
주식회사 케어젠 |
피부 미백 활성을 갖는 펩타이드 및 이의 용도
|
|
EP4136459A1
(en)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Methods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample
|
|
KR20230012539A
(ko)
|
2020-05-13 |
2023-01-26 |
디스크 메디슨, 인크. |
골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체
|
|
CA3188349A1
(en)
|
2020-08-04 |
2022-02-10 |
A. Scott Muerhoff |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
|
US11988671B2
(en)
|
2020-08-04 |
2024-05-21 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting SARS-CoV-2
|
|
CN114773466B
(zh)
*
|
2020-11-26 |
2023-08-29 |
江苏荃信生物医药股份有限公司 |
一种抗人白介素23及包含其的试剂盒及其检测方法
|
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
|
EP4271998A1
(en)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
|
WO2022147178A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Improved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
|
|
WO2022204516A1
(en)
*
|
2021-03-26 |
2022-09-29 |
The General Hospital Corporation |
Humanized mab107
|
|
EP4067375A1
(en)
*
|
2021-03-30 |
2022-10-05 |
Universität Ulm |
Fibril peptides
|
|
US20220381796A1
(en)
|
2021-05-18 |
2022-12-01 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
|
WO2022266034A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
|
WO2023286694A1
(ja)
|
2021-07-13 |
2023-01-19 |
国立大学法人東海国立大学機構 |
炎症性腸疾患を治療するための医薬組成物
|
|
EP4392783A1
(en)
|
2021-08-27 |
2024-07-03 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
|
CN118715440A
(zh)
|
2021-08-31 |
2024-09-27 |
雅培实验室 |
诊断脑损伤的方法和系统
|
|
JP2024534849A
(ja)
|
2021-08-31 |
2024-09-26 |
アボット・ラボラトリーズ |
脳の損傷を診断する方法及びシステム
|
|
JP2024538608A
(ja)
|
2021-09-30 |
2024-10-23 |
アボット・ラボラトリーズ |
脳の損傷を診断する方法及びシステム
|
|
EP4448179A1
(en)
|
2021-12-17 |
2024-10-23 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
|
AU2023226005A1
(en)
*
|
2022-02-23 |
2024-08-29 |
Bright Peak Therapeutics Ag |
Activatable il-18 polypeptides
|
|
CN120167040A
(zh)
|
2022-06-29 |
2025-06-17 |
雅培实验室 |
用于确定生物样本中的gfap的磁性定点照护型系统和测定
|
|
JP2025532597A
(ja)
|
2022-09-15 |
2025-10-01 |
アボット・ラボラトリーズ |
軽度及び超軽度の外傷性脳損傷を区別するためのバイオマーカー及び方法
|
|
WO2024102383A1
(en)
|
2022-11-10 |
2024-05-16 |
Abbott Laboratories |
Methods of identifying macrotroponin in biological samples
|
|
WO2024211475A1
(en)
|
2023-04-04 |
2024-10-10 |
Abbott Laboratories |
Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
|
|
EP4713682A1
(en)
|
2023-04-28 |
2026-03-25 |
Abbott Point of Care Inc. |
Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
|
|
CN121511407A
(zh)
|
2023-04-28 |
2026-02-10 |
雅培实验室 |
晚期肝细胞癌的诊断
|
|
WO2024243819A1
(zh)
*
|
2023-05-30 |
2024-12-05 |
上海洛启生物医药技术有限公司 |
抗白介素18受体的纳米抗体及其应用
|
|
CN120518761B
(zh)
*
|
2023-06-05 |
2025-12-26 |
北京东方百泰生物科技股份有限公司 |
一种结合il-11的抗体、其抗原结合片段及应用
|
|
CN121586728A
(zh)
|
2023-06-20 |
2026-02-27 |
阿波罗Ap43有限公司 |
用于治疗特应性皮炎的抗il-18抗体疗法
|
|
WO2025081059A1
(en)
*
|
2023-10-13 |
2025-04-17 |
The Regents Of The University Of Michigan |
Carriers for drug conjugates
|
|
WO2025111148A1
(en)
|
2023-11-21 |
2025-05-30 |
Abbott Laboratories |
Sample analysis device and methods
|
|
WO2025111147A1
(en)
|
2023-11-21 |
2025-05-30 |
Abbott Laboratories |
Two-dimensional matrix droplet array
|
|
WO2025145020A2
(en)
|
2023-12-28 |
2025-07-03 |
Abbott Laboratories |
Methods, systems, compounds, and kits for determining an analyte of interest in a test sample
|
|
WO2025193825A1
(en)
|
2024-03-13 |
2025-09-18 |
Abbott Laboratories |
Diagnosis and monitoring of liver disease
|
|
WO2025191541A1
(en)
|
2024-03-15 |
2025-09-18 |
Tocris Cookson Limited |
Horseradish peroxidase copolymers, conjugates, and uses thereof
|
|
WO2025198859A1
(en)
|
2024-03-21 |
2025-09-25 |
Abbott Laboratories |
Synthesis of thyroid hormone derivatives and their role as calibrators for thyroid hormone immunoassays
|
|
WO2025230857A1
(en)
|
2024-05-01 |
2025-11-06 |
Abbott Laboratories |
Improved methods for determining cardiac myosin binding protein c in biological samples
|
|
WO2025229563A1
(en)
*
|
2024-05-03 |
2025-11-06 |
Glaxosmithkline Intellectual Property Development Limited |
Methods of treating inflammatory bowel disease
|